Company Search:
Advanced Search
Sponsored Links
Syros Pharmaceuticals Inc Company Snapshot
Syros Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Syros Pharmaceuticals Inc with three other companies in this sector in the United States: Heat Biologics Inc (2016 sales of $341,643.00 of which 100% was Biopharmaceutical), MYOS RENS Technology Inc ($327,000.00 ), and Fibrocell Science Incorporation ($355,000.00 of which 100% was Autologous Cellular Therapeutic).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Syros Pharmaceuticals Inc
  Stock Performance Chart for Syros Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 10.51
(Figures in U.S. Dollars)
1 Week 5.6%   13 Weeks 16.9%  
4 Weeks -37.6%   52 Weeks -11.4%  
Syros Pharmaceuticals Inc Key Data:
  Ticker: SYRS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 317,000
(Year Ending Jan 2017).
Employees: 55
  Currency: U.S. Dollars Market Cap: 276,375,542
  Fiscal Yr Ends: December Shares Outstanding: 26,296,436
  Share Type: Common Closely Held Shares: 4,996,787
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.